These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1015 related items for PubMed ID: 9765768

  • 1. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
    Brundage MD, Crook JM, Lukka H.
    Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
    [Abstract] [Full Text] [Related]

  • 2. Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial.
    Sciuto R, Festa A, Rea S, Pasqualoni R, Bergomi S, Petrilli G, Maini CL.
    J Nucl Med; 2002 Jan; 43(1):79-86. PubMed ID: 11801708
    [Abstract] [Full Text] [Related]

  • 3. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
    Nair N.
    J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
    [Abstract] [Full Text] [Related]

  • 4. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
    Rusthoven J, Bramwell V, Stephenson B.
    Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
    [Abstract] [Full Text] [Related]

  • 5. Strontium 89 therapy for the palliation of pain due to osseous metastases.
    Robinson RG, Preston DF, Schiefelbein M, Baxter KG.
    JAMA; 1995 Aug 02; 274(5):420-4. PubMed ID: 7542352
    [Abstract] [Full Text] [Related]

  • 6. The treatment of osseous metastases of hormone-refractory prostate cancer with external beam radiotherapy and Strontium-89.
    De Ruysscher D, Spaas P, Specenier P.
    Acta Urol Belg; 1996 Sep 02; 64(3):13-9. PubMed ID: 8946776
    [Abstract] [Full Text] [Related]

  • 7. Adjuvant therapy for stage II colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
    Figueredo A, Germond C, Maroun J, Browman G, Walker-Dilks C, Wong S.
    Cancer Prev Control; 1997 Dec 02; 1(5):379-92. PubMed ID: 9765760
    [Abstract] [Full Text] [Related]

  • 8. Bone pain palliation with 85Sr therapy.
    Giammarile F, Mognetti T, Blondet C, Desuzinges C, Chauvot P.
    J Nucl Med; 1999 Apr 02; 40(4):585-90. PubMed ID: 10210217
    [Abstract] [Full Text] [Related]

  • 9. Epirubicin, alone or in combination chemotherapy, for metastatic breast cancer. Provincial Breast Cancer Disease Site Group and the Provincial Systemic Treatment Disease Site Group.
    Findlay BP, Walker-Dilks C.
    Cancer Prev Control; 1998 Jun 02; 2(3):140-6. PubMed ID: 10093625
    [Abstract] [Full Text] [Related]

  • 10. Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
    Bauman G, Charette M, Reid R, Sathya J.
    Radiother Oncol; 2005 Jun 02; 75(3):258-70. PubMed ID: 16299924
    [Abstract] [Full Text] [Related]

  • 11. Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy.
    Malmberg I, Persson U, Ask A, Tennvall J, Abrahamsson PA.
    Urology; 1997 Nov 02; 50(5):747-53. PubMed ID: 9372886
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy in stage IV (metastatic) non-small-cell lung cancer. Provincial Lung Disease Site Group.
    Lopez PG, Stewart DJ, Newman TE, Evans WK.
    Cancer Prev Control; 1997 Nov 02; 1(1):18-27. PubMed ID: 9765723
    [Abstract] [Full Text] [Related]

  • 13. [The efficacy of therapy using 89Sr-strontium chloride in 200 patients with bone metastases of a prostatic cancer].
    Haesner M, Buchali K, Pink V, Lips H.
    Nuklearmedizin; 1992 Mar 02; 31(2):48-52. PubMed ID: 1373485
    [Abstract] [Full Text] [Related]

  • 14. Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: results of a randomized controlled trial.
    Porter AT, McEwan AJ.
    Semin Oncol; 1993 Jun 02; 20(3 Suppl 2):38-43. PubMed ID: 7684865
    [Abstract] [Full Text] [Related]

  • 15. Clinical experience with strontium-89 in prostatic and breast cancer patients.
    Robinson RG, Preston DF, Baxter KG, Dusing RW, Spicer JA.
    Semin Oncol; 1993 Jun 02; 20(3 Suppl 2):44-8. PubMed ID: 8503027
    [Abstract] [Full Text] [Related]

  • 16. Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.
    Papatheofanis FJ.
    J Nucl Med; 1997 Aug 02; 38(8):1175-9. PubMed ID: 9255144
    [Abstract] [Full Text] [Related]

  • 17. [Possibilities of systemic radiotherapy with high-purity 89Sr chloride in the treatment of bone metastases].
    Fomin DK, Tararukhina OB, Nazarov AA.
    Vestn Rentgenol Radiol; 2012 Aug 02; (2):29-31. PubMed ID: 22730757
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Surgical management of early stage invasive breast cancer (stage I and II). Provincial Breast Disease Site Group.
    Mirsky D, O'Brien SE, McCready DR, Newman TE, Whelan TJ, Levine MN.
    Cancer Prev Control; 1997 Aug 02; 1(1):10-7. PubMed ID: 9765722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.